0
0
10/26/23 at 3:00pm
Organization
FDA.gov
Author
Office of the Commissioner
38 words
0
Comments
The agency is advising the public, including healthcare providers, of the possible risks that probiotic products pose to preterm infants in hospital settings.
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-raises-concerns-about-probiotic-products-sold-use-hospitalized-preterm-infants
Create an account
or login to join the discussion